Statement From FDA Commissioner Scott Gottlieb On Researching Medical Uses Of Cannabis

Statement by FDA Commissioner Scott Gottlieb, M.D., on the importance of conducting proper research to prove safe and effective medical uses for the active chemicals in marijuana and its components

By Scott Gottlieb, MD DISTRICT OF COLUMBIA: Over the past decade, we’ve seen a growing interest in the development of therapies derived from marijuana and its components. Proponents of “medical marijuana” advertised its uses for a wide number of medical conditions, such as cancer, multiple sclerosis, post-traumatic stress disorder and anxiety – just to name Read the full article…

Librede Inc. Awarded Highly Competitive Phase II SBIR Grant From NIH

Librede Cannabinoid Map

CALIFORNIA: Librede, an early stage biotechnology company, has been awarded a $1,490,000 Phase II Small Business Innovative Research Grant (SBIR) from the National Center for Complementary and Integrative Health (NCCIH), part of the National Institutes of Health (NIH), to further develop and scale their proprietary yeast-based cannabinoid production platform. The NIH SBIR program is a highly Read the full article…

OWC Pharmaceutical To Begin Testing On Cannabinoid-Infused Psoriasis Cream

Cannabis-infused Psoriasis cream

ISRAEL: OWC Pharmaceutical Research Corp., an Israeli-based developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, announced it has received Institutional Review Board (IRB) approval to conduct safety testing on its proprietary topical crème compound for the treatment of psoriasis and related skin conditions. The approval follows the Company’s February 1, 2017 8K filing Read the full article…

Librede Awarded NIH Funding to Optimize Cannabinoid Production in Yeast

cbd

CALIFORNIA: Librede, a San Diego-based synthetic biology company, has received a Phase I Small Business Innovative Research (SBIR) Grant from the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health (NIH), to improve Cannabidiol production in genetically engineered yeast. Cannabidiol (CBD) is one of several pharmacologically active chemicals (cannabinoids) found in Read the full article…

How Much Does Marijuana Impact Your Driving?

According to the most recent national roadside survey from the National Highway Traffic Safety Administration of weekend nighttime drivers, 8.3 percent had some alcohol in their system and 12.6 percent tested positive for THC—up from 8.6 percent in 2007.

DISTRICT OF COLUMBIA: A rigorous federal research study by the National Institute on Drug Abuse offers new data on the effects of marijuana on driving performance. The exact impact of marijuana on driving ability is a controversial subject—and it’s become more important states continue to loosen their drug laws. And, while drunk driving is on Read the full article…

Cannabis Proves Effective In Treating Crohn’s Disease According To New Study

An on-demand technology service unveils a campaign to deliver free medical marijuana to San Francisco Bay Area patients in about 15 minutes, no purchase is necessary.

TEXAS:  A new clinical study published in the journal Pharmacology and by the National Institute of Health has found that cannabis is effective in treating Crohn’s disease, which is a form of inflammatory bowel disease (IBD). IBDs such as ulcerative colitis and Crohn’s affect over a million people in the United States. Many IBD victims suffer from pain, Read the full article…